Order results by:
| Issue | Title | |
| Vol 17, No 4 (2025) | Experience with the use of sampeginterferon beta-1a in real clinical practice in the Moscow region | Abstract similar documents |
| A. N. Peshkin, V. Yu. Lyzhdvoy, S. V. Kotov, M. V. Sutormin | ||
| "... . Material and methods. Data from 14 patients with relapsing-remitting MS with mild activity who received SPI ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Attitude to reproduced disease modifying therapies in patients with relapsing-remitting multiple sclerosis: results of a medical and sociological study | Abstract similar documents |
| Ya. V. Vlasov, M. V. Churakov, E. V. Sineok, A. N. Boyko | ||
| "... % of cases of deterioration). The majority (87%) of patients with relapsing-remitting MS (RRMS) did ..." | ||
| Vol 16 (2024): (Suppl. 2) | Analysis of the experience with once-weekly intramuscular administration of interferon beta-1a in the Russian population of patients with relapsing-remitting multiple sclerosis | Abstract similar documents |
| F. A. Khabirov, E. V. Granatov, A. Ya. Dykhanov, T. I. Khaibullin | ||
| "... is most pronounced in the initial treatment of relapsing-remitting MS (RRMS) with low or moderate disease ..." | ||
| Vol 13, No 6 (2021) | Changes in retinal structures as markers of multiple sclerosis progression | Abstract similar documents |
| M. O. Poplyak, A. G. Trufanov, A. V. Temniy, D. S. Maltsev, O. B. Chakchir, A. V. Mikheev, D. I. Skulyabin, G. N. Bisaga, I. V. Litvinenko, M. M. Odinak | ||
| "... retinal structures in remitting (RMS) and secondary-progressive (SPMS) MS phenotypes. Patients ..." | ||
| Vol 15, No 6 (2023) | Russian-Belarusian Expert Council “New opportunities in the treatment of patients with multiple sclerosis” (October 1, 2023). Main conclusions of the first meeting | Abstract similar documents |
| A. N. Boyko, V. V. Vashchilin, O. V. Boyko, A. G. Bunyak, D. S. Kasatkin, D. S. Korobko, S. I. Kulikova, N. V. Mazgo, N. V. Makovskaya, S. A. Sivertseva, I. V. Smagina, T. N. Chernukha | ||
| "... is an effective and safe drug of first choice (first-line treatment) for relapsing remitting MS. Divozilimab ..." | ||
| Vol 8, No 4 (2016) | GLATIRAMER ACETATE IS A FIRST-LINE DUAL-ACTION DRUG FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS | Abstract similar documents |
| T. E. Shmidt | ||
| Vol 16 (2024): (Suppl. 2) | Sampeginterferon beta-1a in clinical practice | Abstract similar documents |
| I. A. Sokolova, O. S. Kornakova, E. V. Sokolova | ||
| "... with relapsing-remitting MS who received Tenexia® are presented. In the first clinical observation, the patient ..." | ||
| Vol 16, No 2 (2024) | Effects of rehabilitation on functional independence in daily life, exercise tolerance and quality of life in patients with relapsing-remitting multiple sclerosis | Abstract similar documents |
| Ya. G. Pekhova, M. Yu. Martynov, I. A. Belayeva, A. S. Ryabov, A. A. Vershinin, A. N. Boiko | ||
| "... independence in daily life, exercise tolerance and quality of life (QoL) in patients with relapsing-remitting ..." | ||
| Vol 17, No 2 (2025) | Differences in cerebrospinal fluid microRNA profiles in patients with remitting multiple sclerosis and patients with other neurological diseases | Abstract similar documents |
| М. А. Omarova, М. S. Kozin, А. N. Boyko | ||
| "... Objective: to compare microRNA profiles in cerebrospinal fluid (CSF) of patients with remitting ..." | ||
| Vol 14, No 2 (2022) | Changes in expression of miRNAs from the DLK1-DIO3 locus are characteristic of relapsing-remitting multiple sclerosis regardless of the disease activity | Abstract similar documents |
| N. M. Baulina, A. R. Kabaeva, A. N. Boyko, O. O. Favorova | ||
| "... in the expression of 26 microRNA genes localized in the DLK1-DIO3 locus in men with relapsing-remitting MS (RRMS ..." | ||
| Vol 13, No 3 (2021) | Results of Expert Council meeting on modern principles of treatment optimization in patients with relapsing-remitting multiple sclerosis using anti-CD20 monoclonal antibody | Abstract similar documents |
| A. N. Boyko, N. V. Khachanova, D. S. Korobko, D. S. Kasatkin, Ya. V. Vlasov, E. P. Evdoshenko, E. V. Popova, K. Z. Bakhtiyarova, S. A. Sivertseva | ||
| Vol 16, No 3 (2024) | Experience of cladribine tablets usage in the treatment of multiple sclerosis in the Multiple Sclerosis Centre of the Khanty-Mansi Autonomous Area — Yugra | Abstract similar documents |
| A. A. Sokolova, L. I. Anischenko, L. S. Zemlyanushin, E. A. Rubtsova | ||
| "... Cladribine is a tablet preparation for the treatment of relapsing-remitting multiple sclerosis ..." | ||
| Vol 4, No 2 (2012) | Clinical characteristics of multiple sclerosis in the Tomsk region | Abstract similar documents |
| V M Alifirova, M A Titova | ||
| "... of patients have with remitting MS whereas primarily progressive MS was rarest. The bulk of the patients had ..." | ||
| Vol 11, No 3 (2019) | Mitochondrial genome and risk of multiple sclerosis | Abstract similar documents |
| A. N. Boyko, M. S. Kozin, G. Zh. Osmak, O. G. Kulakova, O. O. Favorova | ||
| "... unrelated patients with relapsing-remitting MS and in 290 unrelated healthy controls matched for gender ..." | ||
| Vol 17, No 4 (2025) | The role of noradrenaline in regulating the interaction between CD14+ monocytes and CD4+ T cells in multiple sclerosis | Abstract similar documents |
| D. V. Nikolaeva, R. R. Zhetishev, A. V. Lopatina, A. A. Sviridova, D. D. Esipova, N. E. Murugina, V. V. Murugin, A. N. Boiko, M. V. Melnikov | ||
| "... in patients with relapsing-remitting MS. Materials and methods. A comprehensive clinical and immunological ..." | ||
| Vol 15 (2023): (Suppl. 1) | Features of multiple sclerosis in childhood in the Republic of Tatarstan | Abstract similar documents |
| A. R. Khaibullina, F. A. Khabirov, T. I. Khaibullin | ||
| "... manifestations were more frequently observed at debut. Moreover, the absolute predominance of the remitting type ..." | ||
| Vol 15 (2023): (Suppl. 1) | Distinctive parameters of gait in patients with multiple sclerosis, depending on the profile of its dysfunction | Abstract similar documents |
| S. A. Ryabov, A. N. Boyko | ||
| "... . Material and methods. We examined 45 patients (37 women, 8 men) with relapsing-remitting (n=38 ..." | ||
| Vol 12, No 3 (2020) | Vitamin D status in patients with multiple sclerosis: an association with insolation, disease course, and HLA-DRB1 gene polymorphism | Abstract PDF (Eng) similar documents |
| I. V. Smagina, K. V. Lunev, S. A. Elchaninova | ||
| "... and methods. The one-stage study enrolled 90 patients with relapsing-remitting MS (a study group) and 87 ..." | ||
| Vol 12, No 1 (2020) | Association of BAFF gene polymorphisms with multiple sclerosis progression | Abstract PDF (Eng) similar documents |
| I. V. Smagina, S. A. Elchaninova, A. S. Palashchenko | ||
| "... . A total of 100 Caucasian patients (24 males and 76 females) with relapsing-remitting MS, who were born ..." | ||
| Vol 8, No 2 (2016) | Glatiramer acetate 40 mg/ml: A review of the results of GALA and GLACIER clinical studies | Abstract similar documents |
| N. Yu. Lashch, A. N. Boiko | ||
| "... -remitting MS (RRMS). The safety profile of GA 40 mg was completely consistent with the well-known profile ..." | ||
| Vol 15 (2023): (Suppl. 1) | MicroRNAs as biomarkers of multiple sclerosis progression | Abstract similar documents |
| N. M. Baulina, I. S. Kiselev, O. G. Kulakova, E. V. Popova, O. O. Favorova, A. N. Boyko | ||
| "... in the fact that there are various types, such as relapsing-remitting MS (RRMS), primary and secondary ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Art therapy possibilities in the complex treatment of patients with multiple sclerosis | Abstract similar documents |
| M. E. Guseva, O. V. Matvievskaya, A. N. Boyko | ||
| "... of neuropsychological disorders and quality of life improvement in patients with relapsing-remitting and secondary ..." | ||
| Vol 7, No 1 (2015) | Time course of changes in the development of gait disorders in multiple sclerosis | Abstract similar documents |
| A. M. Petrov, I. D. Stolyarov, G. G. Shkilnyuk, A. G. Ilves, K. K. Mineev, V. V. Lebedev, T. L. Tsvetkova | ||
| "... biomechanical function were explored in 30 patients with relapsing-remitting MS. Their neurological status ..." | ||
| Vol 6, No 3 (2014) | Visual evoked potentials in examining the visual analyzer in patients with multiple sclerosis | Abstract similar documents |
| S. M. Karpov, Z. B. Pazhigova, E. N. Karpova | ||
| "... duration of the disease with consideration for its clinical form was 3.3±2.2 years in relapsing-remitting ..." | ||
| Online-first | The first experience with the use of ofatumumab for the treatment of pediatric multiple sclerosis in real-life clinical practice in Russia. A case series | Abstract similar documents |
| E. D. Kuzminykh, V. M. Lebedev, V. E. Senchenko, M. S. Cherepyansky, V. A. Gonchar, D. S. Korobko | ||
| "... in patients under 18 years of age with a relapsing-remitting MS (RRMS). In the first observation, a 16-year ..." | ||
| Vol 17, No 1 (2025) | The first experience with the use of ofatumumab for the treatment of pediatric multiple sclerosis in real-life clinical practice in Russia. A case series | Abstract similar documents |
| E. D. Kuzminykh, V. M. Lebedev, V. E. Senchenko, M. S. Cherepyansky, V. A. Gonchar, D. S. Korobko | ||
| "... in patients under 18 years of age with a relapsing-remitting MS (RRMS). In the first observation, a 16-year ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Ways to improve adherence to long-term injection therapy in multiple sclerosis using the example of pegylated interferon-β1a (sampeginterferon β-1a) | Abstract similar documents |
| A. N. Boyko | ||
| "... интерферона-β за счет пегилирования. Не теряя при этом в эффективности, сампэгинтерферон бета-1а (самПЭГ-ИФН-β ..." | ||
| Vol 7, No 2 (2015) | Brain bioelectrical activity changes in patients with poststroke depression and apathy | Abstract similar documents |
| I. V. Kichuk, E. A. Petrova, N. A. Georgievskaya | ||
| "... ЭЭГ в бета-диапазоне отмечалась отсроченно. ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Comparison of medical and social characteristics and quality of life of patients with primary- and secondary-progressive multiple sclerosis | Abstract similar documents |
| Ya. V. Vlasov, N. G. Polyarnaya, A. N. Boyko | ||
| "... , and a higher level of fatigue than patients with relapsing-remitting MS (RRMS). Another unfavorable course ..." | ||
| Vol 16 (2024): (Suppl. 2) | Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaya, E. V. Lysogorskaia, A. N. Boyko | ||
| "... . Пациенты с РС (n=40), получающие терапию интерферонами бета (ИФНβ), у которых был выявлен субоптимальный ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Free circulating miRNA as a potential diagnostic marker in multiple sclerosis (review) | Abstract similar documents |
| M. A. Omarova, M. S. Kozin, A. N. Boyko | ||
| "... with CIS who subsequently developed RMS – remitting multiple sclerosis, and those who had CIS for a long ..." | ||
| Vol 16 (2024): (Suppl. 2) | Experience with the use of cladribine tablets in real-life clinical practice: independent analysis of data from 12 Russian clinical centres | Abstract similar documents |
| A. N. Boyko, V. M. Alifirova, D. V. Pashkovskaya, E. I. Kuchina, S. A. Sivertseva, E. L. Turova, Z. A. Goncharova, O. Yu. Rudenko, Yu. Yu. Pogrebnova, F. A. Khabirov, T. I. Khaibullin, N. N. Babicheva, N. L. Khoroshilova, O. V. Dzundza, O. A. Soldatova, A. N. Belova, G. Е. Sheiko, A. Е. Makarova, N. G. Glavinskaya | ||
| "... relapsing-remitting MS – in 50 (21.3%) and secondary progressive MS with exacerbations – in 6 (2.5%). Only ..." | ||
| Vol 14, No 4 (2022) | The role of oxidative stress in the development of Alzheimer's disease | Abstract similar documents |
| V. N. Nikolenko, N. A. Rizaeva, K. V. Bulygin, V. M. Anokhina, A. A. Bolotskaya | ||
| "... , воспаление, нарушение регуляции гомеостаза металлов, неправильный фолдинг белков. Нами рассмотрена роль бета ..." | ||
| Vol 11, No 1 (2019) | Cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus | Abstract similar documents |
| B. G. Adleyba, G. V. Gavrilov, A. V. Stanishevsky, B. V. Gaydar, D. V. Svistov, V. Yu. Lobzin, K. A. Kolmakova | ||
| "... соответствии с данными литературы являются: бета-амилоид (Aβ) 42, Aβ-40, Aβ-38, sAPPα, sAPPβ, белки t-tau и p ..." | ||
| Vol 11, No 1 (2019) | Primary progressive aphasia | Abstract PDF (Eng) similar documents |
| V. A. Mikhailov, Yu. V. Kotsiubinskaya, N. Yu. Safonova, N. I. Ananieva, I. K. Stulov | ||
| Vol 8, No 3 (2016) | Changes in EEG indices and serotonin concentrations in depression and anxiety disorders | Abstract similar documents |
| I. V. Kichuk, E. A. Petrova, A. A. Mitrofanov, N. V. Solovyeva, V. B. Vilyanov | ||
| "... спектральных характеристик ЭЭГ в бета-диапазоне. При когерентном анализе в бета-диапазоне отмечались ..." | ||
| Vol 16, No 5 (2024) | Resolution of the Expert Council on the problem of early diagnosis of Alzheimer's disease | Abstract similar documents |
| A. N. Bogolepova, E. E. Vasenina, N. V. Vakhnina, S. V. Vorobyеv, S. I. Gavrilova, А. Yu. Emelin, V. V. Zakharov, S. N. Illarioshkin, O. V. Kosivtsova, G. P. Kostyuk, O. S. Levin, E. A. Mkhitaryan, V. А. Parfenov, O. N. Tkacheva, Yu. A. Shpilyukova | ||
| Vol 16 (2024): (Suppl. 2) | Cytokine levels in patients with multiple sclerosis and chronic neuroborreliosis | Abstract similar documents |
| N. S. Baranova, L. A. Ovsyannikova, Ya. S. Ostapenko, N. N. Spirin, A. A. Baranov, M. S. Gris, A. S. Artyukhov, Yu. V. Manyakina | ||
| "... and methods. Fifty-seven patients participated in the study. The group of patients with relapsing-remitting MS ..." | ||
| Vol 3, No 4 (2011) | New criteria for diagnosing Alzheimer's disease | Abstract similar documents |
| A. Yu. Emelin | ||
| "... диагностику с использованием лабораторных и нейровизуализационных маркеров бета-амилоида, нейронального ..." | ||
| Vol 13, No 1 (2021) | Fatigue in patients with chronic inflammatory demyelinating polyneuropathy | Abstract PDF (Eng) similar documents |
| R. A. Gapeshin, E. R. Barantsevich, D. I. Rudenko, T. R. Stuchevskaya, E. A. Gavrilova, M. S. Pushkaryov, A. A. Yakovlev, A. V. Gavrichenko, A. G. Smochilin | ||
| "... motor neuropathy, with a progressive or relapse-remitting course. Fatigue is a condition characterized ..." | ||
| No 1S (2016): | Clinical and electroencephalographic characteristics of chronic tic disorders in children and adolescents | Abstract similar documents |
| N. A. Ermolenko, E. I. Zakharova, I. A. Buchneva | ||
| "... .01), a remitting course (p=0.02), and an early age at the full-scaled picture of tic disorder (p=0.02). CTD therapy ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Results of a study of the quality of life in patients with highly active multiple sclerosis in Russia | Abstract similar documents |
| A. N. Boiko, K. Z. Bakhtiyarova, M. A. Sherman, Z. A. Goncharova, I. V. Smagina, T. I. Khaibullin, N. N. Babicheva, N. N. Spirina, I. A. Yampolskaya-Gosteva, I. A. Sokolova, I. V. Greshnova, V. E. Nikitenkova, I. G. Lukashevich, A. V. Inzhinova, N. A. Malkova, D. S. Korobko, O. V. Boyko, I. S. Lozovskaya | ||
| "... течением ремиттирующего РС (РРС). Пациенты и методы. В исследование были включены данные о 518 пациентах из ..." | ||
| Vol 16, No 3 (2024) | Optic neuritis in various demyelinating diseases | Abstract PDF (Eng) similar documents |
| A. K. Kalashnikova, D. D. Eliseeva, N. A. Andreeva, N. V. Zhorzholadze, I. A. Ronzina, R. Ts. Bembeeva, N. N. Venediktova, M. R. Kalganova, N. L. Sheremet | ||
| "... отдаленном периоде AQP4-OH и MOG-ОНр. Особенностью MOG-ОН была высокая частота ремиттирующего течения, с ..." | ||
| Vol 12, No 5 (2020) | On the heterogeneity of depression in Parkinson’s disease | Abstract similar documents |
| M. R. Nodel, N. N. Yakhno | ||
| "... relapsing-remitting in 9%, progressive in 11%, or remained stable in 64%. The patients with depression ..." | ||
| Vol 8, No 3 (2016) | Epidemiology of multiple sclerosis in the Bryansk Region | Abstract similar documents |
| Yu. N. Yurchenko, A. N. Yurchenko, I. V. Smagina | ||
| "... % of the patients have Groups I, II, and III disability. Remitting MS is more common (69.4% of cases), its secondary ..." | ||
| Vol 11, No 1 (2019) | Anti-MOG syndrome: two case reports | Abstract PDF (Eng) similar documents |
| A. S. Kotov | ||
| "... присоединением миелита, на фоне лечения интерфероном бета произошел рецидив. Во втором случае у пациентки ..." | ||
| Vol 16, No 2 (2024) | Diagnosis of Alzheimer's disease by using biological markers in posterior cortical atrophy | Abstract similar documents |
| D. A. Grishina, N. A. Khayalieva, V. V. Grinyuk, A. Yu. Tyurina | ||
| "... бета-амилоида в цереброспинальной жидкости, что позволило установить диагноз БА. Обсуждаются ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Clinical presentation and course of multiple sclerosis in patients with herpesvirus infection | Abstract similar documents |
| M. S. Gris, N. S. Baranova, N. N. Spirin, D. S. Kasatkin, D. V. Kiselev, E. G. Shipova | ||
| "... -remitting MS; 14% – secondary progressive MS. 98 (80%) patients received disease modifying therapies (DMTs ..." | ||
| Vol 8, No 1 (2016) | Migraine and neck pain: Mechanisms of comorbidity | Abstract similar documents |
| A. S. Zenkevich, E. G. Filatova, N. V. Latysheva | ||
| "... головной боли 3-го пересмотра, версия бета, 2013 г. (МКГБ-3 бета). Для оценки функции антиноцицептивных ..." | ||
| Vol 16, No 2 (2024) | Alzheimer's disease: diagnosis and treatment, errors in patient management | Abstract similar documents |
| V. A. Parfenov, D. A. Grishina, A. Yu. Tyurina | ||
| "... биологических маркеров заболевания, отражающих патологическое образование бета-амилоида и тау-протеина в ..." | ||
| Vol 13, No 1 (2021) | Modern approaches to drug treatment for vestibular vertigo | Abstract similar documents |
| M. V. Zamergrad, S. V. Morozova | ||
| "... – Бетасерк® Лонг), глюкокортикоидов и гентамицина – при болезни Меньера; триптанов, бета-адреноблокаторов ..." | ||
| Vol 9, No 4 (2017) | Current approaches to diagnosing and treating major neurocognitive disorder | Abstract similar documents |
| A. A. Kulesh, V. V. Shestakov | ||
| "... , позитронно-эмиссионная томография с индикатором амилоида, а также оценка содержания бета-амилоида и тау ..." | ||
| Vol 12, No 6 (2020) | Efficacy and safety of antipsychotics in adolescents with an acute psychotic episode in relation to the activity of CYP3A and CYP2D6 isoenzymes | Abstract similar documents |
| D. V. Ivashchenko, A. S. Osipov, E. V. Nazarova, M. A. Ovchinnikova, N. I. Buromskaya, V. V. Smirnov, P. V. Shimanov, R. V. Deitch, T. A. Fainshtein, E. N. Shagovenko, K. A. Akmalova, A. A. Kachanova, E. A. Grishina, L. M. Savchenko, Yu. S. Shevchenko, D. A. Sychev | ||
| "... и на 14-е сутки исследования. Активность CYP3A оценивали по отношению концентрации 6-бета ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Genome-wide polygenic analysis of multiple sclerosis markers | Abstract similar documents |
| Ya. R. Timasheva, T. R. Nasibullin, I. A. Tuktarova, V. V. Erdman, T. R. Galiullin, O. V. Zaplakhova, K. Z. Bakhtiiarova | ||
| "... 9282641), факторов транскрипции SOX8 (rs2744148) и ZBTB46 (rs6062314), бета-маннозидазы MANBA (rs228614 ..." | ||
| Vol 14, No 6 (2022) | Alzheimer's disease and COVID-19 | Abstract similar documents |
| N. N. Koberskaya, F. A. Roshchin | ||
| "... , опосредованные глиальными клетками, что в свою очередь может привести к накоплению бета-амилоида и последующему ..." | ||
| Vol 12, No 4 (2020) | Diagnosis and treatment of migraine: Russian experts' recommendations | Abstract similar documents |
| E. G. Filatova, V. V. Osipova, G. R. Tabeeva, V. A. Parfenov, E. V. Ekusheva, Yu. E. Azimova, N. V. Latysheva, M. V. Naprienko, K. V. Skorobogatykh, A. V. Sergeev, V. A. Golovacheva, E. R. Lebedeva, A. R. Artyomenko, O. V. Kurushina, M. I. Koreshkina, A. V. Amelin, L. R. Akhmadeeva, A. R. Rachin, E. D. Isagulyan, Al. B. Danilov, A. B. Gekht | ||
| "... показана профилактическая терапия, которая включает антидепрессанты, антиконвульсанты, бета-блокаторы ..." | ||
| Vol 11, No 3 (2019) | he amyloid hypothesis of Alzheimer's disease: past and present, hopes and disappointments | Abstract similar documents |
| I. V. Litvinenko, A. Yu. Emelin, V. Yu. Lobzin, K. A. Kolmakova, K. M. Naumov, I. A. Lupanov, G. A. Kilivaeva, M. R. Alizade | ||
| "... исследователи считали причиной болезни гиперпродукцию бета-амилоидного белка (Аβ), то в последние годы все чаще ..." | ||
| Vol 10, No 2 (2018) | Diagnostic criteria for transient ischemic attack | Abstract similar documents |
| E. R. Lebedeva, N. M. Gurary, J. Olesen | ||
| "... России (n=152), страдающих мигренью с аурой, у которых диагноз был установлен согласно МГКБ-3 бета ..." | ||
| Vol 16, No 3 (2024) | Biological markers of Alzheimer's disease in cerebrospinal fluid: clinical and laboratory comparisons | Abstract similar documents |
| K. V. Shevtsova, D. O. Rozhkov, D. A. Grishina, V. V. Grinyuk, V. V. Zakharov, N. M. Kashakanova, N. N. Koberskaya, O. V. Kosivtsova, A. B. Lokshina, Yu. A. Starchina, A. Yu. Tyurina, A. Yu. Fedorova, V. A. Parfenov | ||
| "... маркеров (биомаркеров) БА: снижение уровня бета-амилоида (Ав1-42) и повышение уровня фосфорилированного тау ..." | ||
| Vol 17, No 3 (2025) | Mild cognitive impairment due to cerebrovascular disease and Alzheimer’s | Abstract similar documents |
| V. A. Parfenov, D. A. Grishina, A. B. Lokshina, V. V. Grinyuk, V. V. Zakharov, K. V. Shevtsova | ||
| "... также позитронно-эмиссионная томография (патологическое накопление бета-амилоида и тау-протеина в ..." | ||
| Vol 7, No 1 (2015) | Analysis of the quality of diagnosis and treatment of primary headache in different social groups of the Ural Region | Abstract similar documents |
| E. R. Lebedeva, N. R. Kobzeva, D. V. Gilev, E. Olesen | ||
| "... болей версии 3 бета. Результаты и обсуждение. Выявлены следующие факторы, снижающее качество ..." | ||
| Vol 7, No 1S (2015): Special issue "Epilepsy" | Epilepsy in patients with multiple sclerosis: specific features of diagnosis and therapy | Abstract similar documents |
| Yu. A. Belova, T. I. Yaukushina, I. G. Rudakova, S. V. Kotov | ||
| "... : интерферон бета1а (n=2), глатирамера ацетат (n=5). Проведена ретроспективная оценка течения эпилепсии и РС ..." | ||
| 1 - 62 of 62 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
